Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan · Delayed Price · Currency is TWD 134.50
-0.50 (-0.37%)
Sep 8, 2026, 1:00 PM CST
Gongwin Biopharm Holdings Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 765.98 | 968.9 | 893.47 | 273.59 | 671.51 | 454.12 |
Short-Term Investments | 427.18 | 234.3 | 848.99 | 668.66 | 434.1 | 372.2 |
Trading Asset Securities | 477.68 | 463.03 | 466.79 | - | - | - |
Cash & Short-Term Investments | 1,671 | 1,666 | 2,209 | 942.25 | 1,106 | 826.33 |
Cash Growth | 4.46% | -24.58% | 134.47% | -14.78% | 33.80% | -20.45% |
Accounts Receivable | 12.36 | 16.53 | 14.17 | 10.58 | - | - |
Other Receivables | 7.58 | 8.35 | 12.31 | 4.52 | 4.25 | 0.06 |
Receivables | 19.94 | 24.87 | 26.48 | 15.1 | 4.25 | 0.06 |
Inventory | 5.41 | 0.89 | 3.59 | 11.93 | 0.21 | - |
Prepaid Expenses | 24.86 | 18.62 | 12.89 | 11.36 | 11.11 | - |
Other Current Assets | 0.05 | 157.82 | 180.62 | 138.42 | 215.88 | 93.74 |
Total Current Assets | 1,721 | 1,868 | 2,433 | 1,119 | 1,337 | 920.12 |
Property, Plant & Equipment | 318.72 | 320.85 | 330.89 | 118.32 | 245.05 | 246.76 |
Long-Term Investments | 483.15 | 487.24 | 497.81 | 156.61 | 32.35 | 3.88 |
Other Intangible Assets | 0.73 | 0.83 | 0.37 | 0.19 | - | - |
Other Long-Term Assets | 119.36 | 119.68 | 120.3 | 121.17 | 7.47 | 1.12 |
Total Assets | 2,643 | 2,797 | 3,382 | 1,515 | 1,622 | 1,172 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 5.24 | 0.13 | 0.21 | 0.29 | - | - |
Accrued Expenses | - | 38.4 | 28.81 | 26.37 | 32.63 | 21.97 |
Short-Term Debt | 138.38 | 117.37 | 110.63 | 75.02 | 134.55 | 113.06 |
Current Portion of Leases | 3.31 | 3.12 | 3.21 | 2.12 | 5.01 | 1.99 |
Current Income Taxes Payable | 16.41 | 15.87 | 15.7 | 15.13 | 15.44 | 15.2 |
Other Current Liabilities | 46.72 | 5.53 | 23.6 | 7.44 | 3.62 | 2.54 |
Total Current Liabilities | 210.06 | 180.42 | 182.16 | 126.36 | 191.26 | 154.75 |
Long-Term Leases | 8.24 | 9.25 | 12.91 | 0.03 | 2.18 | 0.1 |
Long-Term Unearned Revenue | 47.1 | 50.41 | 45.01 | 45.08 | 42.03 | 29.57 |
Other Long-Term Liabilities | 51.89 | 39.12 | 41.76 | 32.06 | 13.24 | 0 |
Total Liabilities | 317.28 | 279.2 | 281.84 | 203.53 | 248.7 | 184.43 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,275 | 1,275 | 1,275 | 1,133 | 1,131 | 1,099 |
Additional Paid-In Capital | 3,500 | 3,500 | 3,500 | 1,644 | 1,634 | 1,061 |
Retained Earnings | -1,749 | -1,646 | -1,529 | -1,441 | -1,349 | -1,094 |
Treasury Stock | -646.3 | -532.98 | -166.61 | - | - | - |
Comprehensive Income & Other | -53.03 | -64.88 | 27.14 | -21.35 | -24.77 | -95.34 |
Total Common Equity | 2,326 | 2,531 | 3,107 | 1,315 | 1,392 | 970.72 |
Minority Interest | -0.38 | -13.11 | -6.2 | -3.68 | -18.58 | 16.74 |
Shareholders' Equity | 2,326 | 2,518 | 3,100 | 1,312 | 1,373 | 987.45 |
Total Liabilities & Equity | 2,643 | 2,797 | 3,382 | 1,515 | 1,622 | 1,172 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 149.93 | 129.74 | 126.75 | 77.17 | 141.74 | 115.14 |
Net Cash (Debt) | 1,521 | 1,536 | 2,082 | 865.08 | 963.87 | 711.19 |
Net Cash Growth | 1.85% | -26.22% | 140.73% | -10.25% | 35.53% | -29.07% |
Net Cash Per Share | 12.52 | 12.45 | 17.24 | 7.64 | 8.67 | 6.49 |
Filing Date Shares Outstanding | 120.99 | 122.62 | 126.06 | 113.34 | 113.09 | 109.92 |
Total Common Shares Outstanding | 120.99 | 122.62 | 126.06 | 113.34 | 113.09 | 109.92 |
Working Capital | 1,511 | 1,688 | 2,251 | 992.7 | 1,146 | 765.37 |
Book Value Per Share | 19.23 | 20.64 | 24.64 | 11.61 | 12.31 | 8.83 |
Tangible Book Value | 2,325 | 2,530 | 3,106 | 1,315 | 1,392 | 970.72 |
Tangible Book Value Per Share | 19.22 | 20.63 | 24.64 | 11.61 | 12.31 | 8.83 |
Land | - | 228.65 | 228.65 | 49.69 | 155 | 155 |
Buildings | - | 76.22 | 75.29 | 52.95 | 69.59 | 69.23 |
Machinery | - | 62.62 | 62.66 | 63.43 | 56.76 | 54.91 |
Construction In Progress | - | - | - | - | - | 0.54 |
Leasehold Improvements | - | 10.99 | 11.3 | 3.75 | 3.75 | 3.75 |